M. Mietzel

732 total citations
19 papers, 414 citations indexed

About

M. Mietzel is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Radiation. According to data from OpenAlex, M. Mietzel has authored 19 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Radiology, Nuclear Medicine and Imaging, 6 papers in Oncology and 5 papers in Radiation. Recurrent topics in M. Mietzel's work include Advances in Oncology and Radiotherapy (5 papers), Multiple Myeloma Research and Treatments (5 papers) and Advanced Radiotherapy Techniques (5 papers). M. Mietzel is often cited by papers focused on Advances in Oncology and Radiotherapy (5 papers), Multiple Myeloma Research and Treatments (5 papers) and Advanced Radiotherapy Techniques (5 papers). M. Mietzel collaborates with scholars based in United States and Poland. M. Mietzel's co-authors include Kent A. Griffith, Keith Stockerl‐Goldstein, Tara Anderson, Ravi Vij, Sundar Jagannath, Daniel R. Couriel, Diane E. Durecki, Andrzej Jakubowiak, Kristen Detweiler‐Short and Dominik Dytfeld and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

M. Mietzel

15 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Mietzel United States	6	327	309	182	30	25	19	414
Maximilian Fleischmann Germany	9	111 0.3×	109 0.4×	96 0.5×	23 0.8×	32 1.3×	31	271
Louise Flanagan United Kingdom	11	122 0.4×	170 0.6×	109 0.6×	40 1.3×	15 0.6×	31	302
Noa Biran United States	12	322 1.0×	256 0.8×	226 1.2×	38 1.3×	35 1.4×	89	427
Alissa Visram Canada	12	244 0.7×	158 0.5×	198 1.1×	27 0.9×	41 1.6×	57	403
Serena Rocchi Italy	9	255 0.8×	180 0.6×	157 0.9×	18 0.6×	33 1.3×	31	301
Katia Mancuso Italy	8	240 0.7×	162 0.5×	154 0.8×	23 0.8×	25 1.0×	39	281
Raid G. Ossi United States	3	499 1.5×	329 1.1×	268 1.5×	13 0.4×	53 2.1×	4	545
Nuria Navarro Coy United Kingdom	6	518 1.6×	428 1.4×	351 1.9×	26 0.9×	44 1.8×	11	567
Christopher Strouse United States	9	159 0.5×	129 0.4×	94 0.5×	20 0.7×	25 1.0×	49	319
Xenofon Papanikolaou United States	7	241 0.7×	167 0.5×	150 0.8×	8 0.3×	50 2.0×	30	310

Countries citing papers authored by M. Mietzel

Since Specialization

Citations

This map shows the geographic impact of M. Mietzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Mietzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Mietzel more than expected).

Fields of papers citing papers by M. Mietzel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Mietzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Mietzel. The network helps show where M. Mietzel may publish in the future.

Co-authorship network of co-authors of M. Mietzel

This figure shows the co-authorship network connecting the top 25 collaborators of M. Mietzel. A scholar is included among the top collaborators of M. Mietzel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Mietzel. M. Mietzel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Dykstra, Michael, Huiying Yin, Mark Zaki, et al.. (2024). Microboost in Localized Prostate Cancer: Analysis of a Statewide Quality Consortium. Advances in Radiation Oncology. 9(11). 101629–101629. 1 indexed citations

Yin, Haidi, Denise Kendrick, Kent A. Griffith, et al.. (2024). Analysis of Patient Reported Outcomes in the Prevention of Acute Radiation Dermatitis with Topical Therapies. International Journal of Radiation Oncology*Biology*Physics. 120(2). e315–e315.

Dykstra, Michael, et al.. (2024). Prospective Evaluation of Acute Toxicity from Tumor Bed Boost Following Whole Breast Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 120(2). e306–e306.

Dykstra, Michael, Huiying Yin, Patrick W. McLaughlin, et al.. (2024). Variation in Androgen Deprivation Therapy Use Among Men With Intermediate-Risk Prostate Cancer: Results From a Statewide Radiation Oncology Quality Consortium. International Journal of Radiation Oncology*Biology*Physics. 120(4). 999–1007. 2 indexed citations

Dykstra, Michael, Huiying Yin, Patrick W. McLaughlin, et al.. (2024). Microboost dose escalation for localized prostate cancer within a statewide radiation oncology quality consortium.. Journal of Clinical Oncology. 42(4_suppl). 298–298. 1 indexed citations

Hayman, James A., et al.. (2024). Advancing quality of care using a knowledge transfer approach to foster the use of single-fraction radiation therapy.. JCO Oncology Practice. 20(10_suppl). 288–288.

Dykstra, Michael, Huiying Yin, Patrick W. McLaughlin, et al.. (2024). Contemporary androgen deprivation therapy practice patterns in locally advanced prostate cancer treated with definitive radiotherapy: Prospective results from a statewide radiation oncology quality consortium.. Journal of Clinical Oncology. 42(4_suppl). 307–307.

Cousins, Matthew M., Michael Dykstra, M. Mietzel, et al.. (2023). Cannabis Use Patterns among Patients with Early-Stage Breast Cancer in a Large Multicenter Cohort from a State with Legalized Adult Non-Medical Cannabis. International Journal of Radiation Oncology*Biology*Physics. 117(2). e95–e95. 1 indexed citations

Chapman, Christina, Reshma Jagsi, Kent A. Griffith, et al.. (2022). Mediators of Racial Disparities in Heart Dose Among Whole Breast Radiotherapy Patients. JNCI Journal of the National Cancer Institute. 114(12). 1646–1655. 7 indexed citations

10.

LaBonte, Melissa J., Ruimei Ma, Robin Marsh, et al.. (2022). Evaluation of Dose Accuracy in the Near-Surface Region for Whole Breast Irradiation Techniques in a Multi-institutional Consortium. Practical Radiation Oncology. 12(4). e317–e328. 4 indexed citations

11.

Jagsi, Reshma, Kent A. Griffith, Frank A. Vicini, et al.. (2022). Identifying Patients Whose Symptoms Are Underrecognized During Treatment With Breast Radiotherapy. JAMA Oncology. 8(6). 887–887. 26 indexed citations

12.

Jagsi, Reshma, Matthew J. Schipper, M. Mietzel, et al.. (2022). The Michigan Radiation Oncology Quality Consortium: A Novel Initiative to Improve the Quality of Radiation Oncology Care. International Journal of Radiation Oncology*Biology*Physics. 113(2). 257–265. 5 indexed citations

13.

Jaworski, E, Huiying Yin, Kent A. Griffith, et al.. (2021). Contemporary Practice Patterns for Palliative Radiation Therapy of Bone Metastases: Impact of a Quality Improvement Project on Extended Fractionation. Practical Radiation Oncology. 11(6). e498–e505. 3 indexed citations

14.

Brown, Anna M., Reshma Jagsi, Kent A. Griffith, et al.. (2020). The Role of Facility Variation on Racial Disparities in Use of Hypofractionated Whole Breast Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 107(5). 949–958. 15 indexed citations

15.

Jasielec, Jagoda, Dominik Dytfeld, Kent A. Griffith, et al.. (2014). Minimal Residual Disease Status Predicts Progression-Free Survival in Newly Diagnosed Multiple Myeloma (NDMM) Patients Treated with Carfilzomib, Lenalidomide, and Low-Dose Dexamethasone (KRd). Blood. 124(21). 2127–2127. 4 indexed citations

16.

Jasielec, Jagoda, Dominik Dytfeld, Kent A. Griffith, et al.. (2013). Predictors Of Treatment Outcome With The Combination Of Carfilzomib, Lenalidomide, and Low-Dose Dexamethasone (CRd) In Newly Diagnosed Multiple Myeloma (NDMM). Blood. 122(21). 3220–3220. 3 indexed citations

17.

Jakubowiak, Andrzej, Dominik Dytfeld, Kent A. Griffith, et al.. (2013). Treatment outcome with the combination of carfilzomib, lenalidomide, and low-dose dexamethasone (CRd) for newly diagnosed multiple myeloma (NDMM) after extended follow-up.. Journal of Clinical Oncology. 31(15_suppl). 8543–8543. 13 indexed citations

18.

Jakubowiak, Andrzej, Dominik Dytfeld, Kent A. Griffith, et al.. (2012). A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma. Blood. 120(9). 1801–1809. 311 indexed citations

19.

Jakubowiak, Andrzej, Dominik Dytfeld, Sundar Jagannath, et al.. (2011). Final Results of a Frontline Phase 1/2 Study of Carfilzomib, Lenalidomide, and Low-Dose Dexamethasone (CRd) in Multiple Myeloma (MM). Blood. 118(21). 631–631. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact